Paradoxical SERCA2a Dysregulation Contributes to Atrial Fibrillation in a Model of Diet-Induced Obesity
Obesity is a major risk factor for atrial fibrillation (AF), the most common serious cardiac arrhythmia, but the molecular mechanisms underlying obesity-induced AF remain unclear. In this study, we subjected mice to a chronic high-fat diet and acute sympathetic activation to investigate how obesity promotes AF. Surface electrocardiography revealed that obesity and sympathetic activation synergize during intracardiac tachypacing to induce AF. At the cellular level, this combination facilitated delayed afterdepolarizations in atrial myocytes, implicating altered Ca<sup>2+</sup> dynamics. Interestingly, obesity did not affect the expression of key atrial Ca<sup>2+</sup>-handling proteins, including the cardiac sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA2a). However, obesity increases the proportion of inhibitory phospholamban (PLN) monomers and decreases PLN phosphorylation, suggesting reduced SERCA2a activity. Paradoxically, Ca<sup>2+</sup> reuptake in atrial myocytes from obese mice was similar to that achieved by potent small-molecule SERCA2a activators. We found that adrenergic stimulation increased Ca<sup>2+</sup> transient amplitude without altering Ca<sup>2+</sup> reuptake in myocytes from obese mice. Transcriptomic analysis revealed that a high-fat diet upregulated neuronatin, a protein involved in obesity that enhances SERCA2-mediated Ca<sup>2+</sup> reuptake in neurons. We propose that obesity enables SERCA2a activation independently of PLN regulation, while adrenergic stimulation triggers arrhythmogenic Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release, promoting AF. In conclusion, this study demonstrates that obesity causes a paradoxical dysregulation of SERCA2a in atrial myocytes, with increased activity despite higher levels of inhibitory PLN monomers and reduced PLN phosphorylation. These findings offer new insights into the cellular mechanisms of obesity-induced AF and suggest potential therapeutic targets.
Authors
- Todd J. Herron (ORCID: https://orcid.org/0000-0002-2788-7479)
- Jianrui Song (ORCID: https://orcid.org/0000-0001-5472-4483)
- André Monteiro da Rocha (ORCID: https://orcid.org/0000-0003-3324-3773)
- Daniel R. Goldstein (ORCID: https://orcid.org/0000-0001-6695-979X)
- Justus Anumonwo
- L. Michel Espinoza‐Fonseca (ORCID: https://orcid.org/0000-0002-7356-5681)
- Guadalupe Guerrero‐Serna (ORCID: https://orcid.org/0000-0001-9130-1850)
- Daniel J. Tyrrell (ORCID: https://orcid.org/0000-0002-0811-6724)
- Carlos Cruz‐Cortés (ORCID: https://orcid.org/0000-0002-3781-9664)
- Daniela Ponce‐Balbuena (ORCID: https://orcid.org/0000-0002-7413-5325)
- Danyal S. Raza
Institutions
- University of Michigan (US)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3390/ijms26125603
- Citations
- 2
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- American Heart Association
- University of Michigan
- Medical School, University of Michigan
- National Institute of General Medical Sciences